FI870580A0 - Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer. - Google Patents

Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.

Info

Publication number
FI870580A0
FI870580A0 FI870580A FI870580A FI870580A0 FI 870580 A0 FI870580 A0 FI 870580A0 FI 870580 A FI870580 A FI 870580A FI 870580 A FI870580 A FI 870580A FI 870580 A0 FI870580 A0 FI 870580A0
Authority
FI
Finland
Prior art keywords
aminopropylaminer
saosom
anvaendbara
alcoxi
cardiovascular
Prior art date
Application number
FI870580A
Other languages
English (en)
Other versions
FI870580A (fi
Inventor
Philip Paul Grous
Richard Joseph Mohrbacher
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of FI870580A0 publication Critical patent/FI870580A0/fi
Publication of FI870580A publication Critical patent/FI870580A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI870580A 1986-02-12 1987-02-11 Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer. FI870580A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/828,923 US4727072A (en) 1986-02-12 1986-02-12 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents

Publications (2)

Publication Number Publication Date
FI870580A0 true FI870580A0 (fi) 1987-02-11
FI870580A FI870580A (fi) 1987-08-13

Family

ID=25253093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870580A FI870580A (fi) 1986-02-12 1987-02-11 Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.

Country Status (12)

Country Link
US (1) US4727072A (fi)
EP (1) EP0237191A1 (fi)
JP (1) JPS62215577A (fi)
KR (1) KR870007882A (fi)
CN (1) CN87100686A (fi)
AU (2) AU599954B2 (fi)
DK (1) DK69987A (fi)
FI (1) FI870580A (fi)
HU (1) HU198032B (fi)
NO (1) NO169069C (fi)
NZ (1) NZ219161A (fi)
ZA (1) ZA87988B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
DE3726633A1 (de) * 1987-08-11 1989-02-23 Boehringer Mannheim Gmbh Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3726632A1 (de) * 1987-08-11 1989-05-18 Boehringer Mannheim Gmbh 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4888335A (en) * 1988-07-25 1989-12-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5185362A (en) * 1988-09-14 1993-02-09 Mcneilab, Inc. Diphenylamine cardiovascular agents, compositions and use
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30577A (en) * 1860-11-06 Truss-bridge
BE795735A (fr) * 1972-03-06 1973-06-18 Cerm Cent Europ Rech Mauvernay Nouvelles ethylenediamines substituees a activite cardiovasculaire
US4430338A (en) * 1980-09-30 1984-02-07 Akzo N.V. Method of treatment patients at risk of sudden death
NO149468C (no) * 1981-07-17 1984-04-25 Vefi As Rykkegrep.
DK156396C (da) * 1983-09-27 1990-01-08 Cerm Cent Europ Rech Mauvernay 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
GB8330197D0 (en) * 1983-11-11 1983-12-21 Akzo Nv Ether of n-propanolamine derivative
DE3468684D1 (de) * 1983-11-11 1988-02-18 Akzo Nv Ether of n-propanolamine derivative
FR2558161B1 (fr) * 1984-01-18 1987-01-23 Cerm Cent Europ Rech Mauvernay 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents

Also Published As

Publication number Publication date
KR870007882A (ko) 1987-09-22
NO870533D0 (no) 1987-02-11
DK69987A (da) 1987-08-13
HUT46660A (en) 1988-11-28
AU5988990A (en) 1990-11-15
ZA87988B (en) 1988-09-28
CN87100686A (zh) 1987-10-14
DK69987D0 (da) 1987-02-11
AU599954B2 (en) 1990-08-02
AU621003B2 (en) 1992-02-27
US4727072A (en) 1988-02-23
HU198032B (en) 1989-07-28
NO169069C (no) 1992-05-06
EP0237191A1 (en) 1987-09-16
AU6868087A (en) 1987-08-13
JPS62215577A (ja) 1987-09-22
NZ219161A (en) 1989-03-29
NO169069B (no) 1992-01-27
NO870533L (no) 1987-08-13
FI870580A (fi) 1987-08-13

Similar Documents

Publication Publication Date Title
DE3764993D1 (de) Deckenbauweise.
FI871151A (fi) Anordning foer extrahering av en portionsinsats.
FI870841A (fi) Foerfarande foer karbonylisering av olefiniskt omaettade foereningar medelst palladiumkatalyt.
NO874179D0 (no) Sammenleggbar oppbygging.
FI77063B (fi) Foerfarande foer effektivering av fibersuspensionstvaett.
FI871541A (fi) Foerbaettring av glasskivors uppvaermningsteknik.
FI860502A0 (fi) Anordning foer skaerpning av knivar.
FI82029B (fi) Anordning foer vaermehaerdning av glasskivor.
FI873441A (fi) Reversibel fasfoeraendringskomposition av hydraterad kalciumbromid.
FI871252A (fi) Foerfarande foer framstaellning av en elektroluminiscerande tunnfilmsstruktur.
FI870580A (fi) Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.
FI871516A0 (fi) Anordning foer skoerning av fanerskivor.
ES2023141B3 (es) Algunas 3-benzoil-4-oxolactamas.
FI864797A0 (fi) Foerfarande foer framstaellning av en alkoholdryck.
FI852221A0 (fi) Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner.
FI860245A0 (fi) Foerfarande foer identifiering av en traeytas ytegenskaper.
DE3774371D1 (de) Baueinheit.
FI860623A0 (fi) Foerfarande foer framstaellning av fiskfoderpellets.
FI860379A0 (fi) Foerfarande foer framstaellning av ytbelaeggning.
FI871703A0 (fi) Foerfarande foer framstaellning av organiskt zinkkomplex.
FI870118A (fi) Bestraolningsanordning av solenergi foer medicinskt bruk.
FI874604A0 (fi) Foerfarande foer kontroll av stabila blandbiocenoser.
NL192687B (nl) Gebouw.
FI861767A0 (fi) Slaepvagnstabilisator foer traktor. fastsaettande av traktors maskskydd.
FI860592A0 (fi) Anordning foer dosering av vaetska.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MCNEILAB, INC.